BlackRock Investment Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$965K Sell
42,785
-505
-1% -$12.2K ﹤0.01% 2719
2016
Q3
$991K Buy
43,290
+196
+0.5% +$4.38K ﹤0.01% 2671
2016
Q2
$922K Sell
43,094
-5,892
-12% -$186K ﹤0.01% 2691
2016
Q1
$1.68M Buy
48,986
+1,201
+3% +$31.7K ﹤0.01% 2114
2015
Q4
$1.31M Buy
47,785
+460
+1% +$12.6K ﹤0.01% 2398
2015
Q3
$1.42M Buy
47,325
+711
+2% +$23.3K ﹤0.01% 2330
2015
Q2
$1.96M Buy
+46,614
New +$2.2M ﹤0.01% 2253

Other funds holding ATEX

BlackRock Investment Management's ATEX Position: Q4 2016 in Review

BlackRock Investment Management reduced its Anterix (ATEX) stake by 1.2% in Q4 2016, selling an estimated $12.2K and leaving 42,785 shares worth $965K. The position accounts for ﹤0.01% of the portfolio, ranked #2719.

BlackRock Investment Management first reported a position in ATEX in Q2 2015 and has held it in 7 quarters since. The position peaked at $1.96M in Q2 2015. 55 funds tracked by Wall St. Rank hold ATEX as of Q4 2016.

  • BlackRock Investment Management held 42,785 shares of Anterix worth $965K as of Q4 2016.
  • BlackRock Investment Management sold 505 Anterix shares in Q4 2016, an estimated $12.2K.
  • Anterix made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2719 holding.
  • BlackRock Investment Management first reported a position in Anterix in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Investment Management's Anterix position peaked at $1.96M in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Anterix as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.